IP Library Granted Patent US 10,087,206
Granted Patent B2
US 10,087,206 · App. 15/519,471 · Granted Oct 2, 2018

Scalable synthesis of reduced toxicity derivative of amphotericin B

Inventors: Martin D. Burke (Champaign, IL); Brice E. Uno (Champaign, IL); Souvik Rakshit (Uluberia, IN)
Assignee: The Board of Trustees of the University of Illinois
C07H17/08C07H1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,206
App. No.
15/519,471
Granted
Oct 2, 2018
Kind
B2
Abstract

Disclosed is a simplified, readily scalable series of individual methods that collectively constitute a method for the synthesis of C2′epiAmB, an efficacious and reduced-toxicity derivative of amphotericin B (AmB), beginning from AmB. Also provided are various compounds corresponding to intermediates in accordance with the series of methods.

Claims (49)

1. A compound, represented by

wherein, independently for each occurrence,

R 1 is C(O)OR a ;

R 2 is selected from the group consisting of 2-alken-1-yl, benzyl, and (R b ) 3 Si—;

R 3 is substituted or unsubstituted aryl, or C 1 -C 6 alkyl;

R 5 is (R b ) 3 Si—;

R 6 is —C(O)R c ;

R a is selected from the group consisting of 2-alken-1-yl, tert-butyl, and benzyl;

R b is substituted or unsubstituted aryl, or C 1 -C 6 alkyl; and

R c is substituted or unsubstituted aryl.

2. The compound of claim 1 , wherein R a is 2-alken-1-yl; R 2 is 2-alken-1-yl; R 3 is substituted or unsubstituted aryl; R c is substituted or unsubstituted phenyl; and R b is C 1 -C 6 alkyl.

3. The compound of claim 1 , represented by

4. A compound, represented by

wherein, independently for each occurrence,

R 1 is C(O)OR a ;

R 2 is selected from the group consisting of 2-alken-1-yl, benzyl, and (R b ) 3 Si—;

R 3 is substituted or unsubstituted aryl, or C 1 -C 6 alkyl;

R 5 is (R b ) 3 Si—;

R a is selected from the group consisting of 2-alken-1-yl, tert-butyl, and benzyl; and

R b is substituted or unsubstituted aryl, or C 1 -C 6 alkyl.

5. The compound of claim 4 , wherein R a is 2-alken-1-yl; R 2 is 2-alken-1-yl; R 3 is substituted or unsubstituted aryl; and R b is C 1 -C 6 alkyl.

6. The compound of claim 4 , represented by

7. A compound, represented by

wherein, independently for each occurrence,

R 1 is C(O)OR a ;

R 2 is selected from the group consisting of 2-alken-1-yl, benzyl, and (R b ) 3 Si—;

R 3 is substituted or unsubstituted aryl, or C 1 -C 6 alkyl;

R a is selected from the group consisting of 2-alken-1-yl, tert-butyl, and benzyl; and

R b is substituted or unsubstituted aryl, or C 1 -C 6 alkyl.

8. The compound of claim 7 , wherein R a is 2-alken-1-yl; R 2 is 2-alken-1-yl; and R 3 is substituted or unsubstituted aryl.

9. The compound of claim 7 , represented by

10. A compound, represented by

wherein, independently for each occurrence,

R 3 is substituted or unsubstituted aryl, or C 1 -C 6 alkyl.

11. The compound of claim 10 , wherein R 3 is substituted or unsubstituted aryl.

12. The compound of claim 10 , represented by

13. A method of making 2′ epiAmB

comprising the step of:

wherein, independently for each occurrence,

R 1 is C(O)OR a ;

R 2 is selected from the group consisting of 2-alken-1-yl, benzyl, and (R b ) 3 Si—;

R 3 is substituted or unsubstituted aryl, or C 1 -C 6 alkyl;

R 5 is (R b ) 3 Si—;

R 6 is —C(O)R c ;

R a is selected from the group consisting of 2-alken-1-yl, tert-butyl, and benzyl;

R b is substituted or unsubstituted aryl, or C 1 -C 6 alkyl;

R c is substituted or unsubstituted aryl;

R d is C 1 -C 6 alkyl or aryl; and

solvent 7 is a nonpolar aprotic solvent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2018
From: BURKE, MARTIN D.; UNO, BRICE E.; RAKSHIT, SOUVIK
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 045237/0844 →
CONFIRMATORY LICENSE Recorded Mar 2, 2018
From: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045492/0378 →
Continuity (2)
Provisional Application 62065330 · Oct 17, 2014
Related Publication 20170233427A1 · Aug 17, 2017